ArticleJournal of clinical hypertension (Greenwich, Conn.)2011
Impacting population cardiovascular health through a community-based practice network: update on an ASH-supported collaborative.
Article in Journal of clinical hypertension (Greenwich, Conn.), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed.
- Phone-based Intervention under Nurse Guidance after Stroke (PINGS): study protocol for a randomized controlled trial.Trials · 2016Trial
- Achieved blood pressures in the secondary prevention of small subcortical strokes (SPS3) study: challenges and lessons learned.American journal of hypertension · 2014Trial
- Rationale, design, and implementation of aggressive risk factor management in the Stenting and Aggressive Medical Management for Prevention of Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) trial.Circulation. Cardiovascular quality and outcomes · 2012Trial
- Article
- Article
- Drivers and scorecards to improve hypertension control in primary care practice: Recommendations from the HEARTS in the Americas Innovation Group.Lancet regional health. Americas · 2022Article
- [Drivers and scorecards to improve hypertension control in primary care practice: Recommendations from the HEARTS in the Americas Innovation GroupFatores impulsionadores e scorecards para melhorar o controle da hipertensão arterial na atenção primária: recomendações do Grupo de Inovação da Iniciativa HEARTS nas Américas].Revista panamericana de salud publica = Pan American journal of public health · 2022Article
- [Drivers and scorecards to improve hypertension control in primary care practice: Recommendations from the HEARTS in the Americas Innovation GroupFactores impulsores y métodos de puntuación para mejorar el control de la hipertensión en la práctica clínica de la atención primaria: recomendaciones del grupo de innovación de HEARTS en las Américas].Revista panamericana de salud publica = Pan American journal of public health · 2022Article
- Rationale, Design, and Implementation of Intensive Risk Factor Treatment in the CREST2 Trial.Stroke · 2020Article
- Hypertension in Blacks: Unanswered Questions and Future Directions for the JHS (Jackson Heart Study).Hypertension (Dallas, Tex. : 1979) · 2017Review
- Impact of Implementing the 2013 ACC/AHA Cholesterol Guidelines on Vascular Events in a Statewide Community-Based Practice Registry.Journal of clinical hypertension (Greenwich, Conn.) · 2016Article
- Hypertension Control Cascade: A Framework to Improve Hypertension Awareness, Treatment, and Control.Journal of clinical hypertension (Greenwich, Conn.) · 2016Article
- Formation of community-based hypertension practice networks: success, obstacles, and lessons learned.Journal of clinical hypertension (Greenwich, Conn.) · 2014Article
- Rationale for establishing a mechanism to increase reimbursement to hypertension specialists.Journal of clinical hypertension (Greenwich, Conn.) · 2013Article
- Initial monotherapy and combination therapy and hypertension control the first year.Hypertension (Dallas, Tex. : 1979) · 2012Article
- Progression is accelerated from prehypertension to hypertension in blacks.Hypertension (Dallas, Tex. : 1979) · 2011Article
- Comparative effectiveness research in the "real" world: lessons learned in a study of treatment-resistant hypertension.Journal of the American Society of Hypertension : JASHReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
The Hypertension Initiative began in 1999 to help transition South Carolina from a leader in cardiovascular disease (CVD) to a model of heart and vascular health. Goals were to reduce heart disease and stroke by 50% by promoting healthy lifestyles and access to effective care and medications. Continuing medical education was used to train providers, encourage physicians to become American Society of Hypertension (ASH)-certified hypertension specialists and recruit practices into the community-based practice network (CBPN). Practice data audit with provider specific feedback is a key quality improvement tool. With ASH support, the CBPN has grown to 197 practices with approximately 1.6 million patients (approximately 700,000 hypertensives). Clinical data are obtained from electronic health records and quarterly provider feedback reports are generated. Hypertension, hypercholesterolemia, and diabetes control rose and South Carolina's ranking improved from 51st to 35th in CVD mortality from 1995 to 2006. The Hypertension Initiative expanded to the Outpatient Quality Improvement Network (O'QUIN) to encompass comparative effectiveness research and other chronic diseases. Lessons learned include: trust enables success, addressing practice priorities powers participation, infrastructure support must be multilateral, and strategic planning identifies opportunities and pitfalls. A collaborative practice network is attainable that produces positive, sustainable, and growing impacts on cardiovascular and other chronic diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.